Latisse™ is believed to affect the growth (anagen) phase of the eyelash hair cycle by increasing the length of the growth phase and increasing the number of hairs along the eyelid margin. The onset of action is gradual with most users seeing a significant improvement in the length and number of lashes by 2 months. If Latisse™ is discontinued the eyelashes and eyelids will return to their previous appearance over several weeks to months.
Benefits :
Helps promote longer lashes
Increases the number of hairs along the eyelid margin
What are the risks and possible side effects of using Latisse™?
The following side effects can occur while using this product: Eye irritation and itching, Conjunctival hyperemia or red or dry eyes and or eyelid redness
Although rare, Latisse™ has the potential to permanently increase the brown pigmentation of the iris (colored part of the eyeball, inside the eye)
Latisse™ may cause hyperpigmentation or darkening of the eyelid skin which may or may not be reversible upon discontinuation of the treatment
Latisse™ may lower intraocular pressure (IOP) or pressure inside the eye; however, the magnitude of this reduction is usually not a cause for concern:
a. If you have a history of abnormal eye pressures or glaucoma you should only use Latisse™ under the close supervision of your ophthalmologist
b. Inform anyone conducting an eye pressure examination that you are using Latisse™.
You should inform your ophthalmologist that you are using Latisse™ if eye surgery is planned
Do not use Latisse™ if you are allergic or hypersensitive to bimatoprost (LumiganR) or any other ingredient in this product
Latisse™ is intended for use on the skin at the base of the eyelashes of the UPPER eyelids only.
DO NOT APPLY to the lower eyelids as this will increase the chance of side effects such as hyperpigmentation or darkening of the eyelid skin.
You should discontinue use of Latisse™ and call
your physician immediately if you develop an eye infection, sudden decrease in vision, suffer eye trauma, or develop eye or eyelid reactions.